Principles of psoriasis and therapeutic approach in pregnancy: literature review
DOI:
https://doi.org/10.29176/2590843X.1519Keywords:
Psoriasis, Pregnancy, Therapeutics, Treatment outcomeAbstract
Psoriasis is one of the most common dermatologic diseases affecting female patients with childbearing potential, pregnancy and during the postpartum period. Its manifestations are categorized by type of lesion, extension, severity, systemic compromise, and quality of life affection. Pregnancy is a state full of physiologic changes in which the psoriasis course is uncertain because it can resolve or diminish and in others exacerbate requiring pharmacological therapy.
This article will explain the possible etiologies, pathophysiology, different morphology types, diagnosis, treatment and possible complications for the mother and the fetus. One of the pregnancy goals is to accomplish the maternal-fetal unit safety, based on the classification of the FDA measuring the benefit or risk and developing a useful guide for clinical practice.
Author Biographies
Daniel Barquero-Orias
Médico General, Universidad de Ciencias Médicas. Costa Rica. https://orcid.org/0000-0001-7627-1358
María Camila Martínez-Franco
Médico General, Universidad El Bosque. Bogotá D.C, Colombia. ORCID https://orcid.org/0000-0002-6863-7329
References
1. Jurado F, Páez F. De la evidencia a la experiencia: concordancia en el manejo tópico de la psoriasis. Rev Med Inst Mex Seguro Soc. 2016;54(3):304-11.
2. Polachek A, Li S, Polachek I, Chandran V, Gladman D. Psoriatic arthritis disease activity during pregnancy and the first-year postpartum. Semin Arthritis Rheum. 2017;46(6):740-5. doi:10.1016/j.semarthrit.2017.01.002.
3. Polachek A, Polachek Shlomi I, Spitzer K, Pe¬reira D, Ye J, Chandran V, Laskin CA, Gladman DD. Outcome of pregnancy in women with psoriatic arthritis compared to healthy con¬trols. Clin Rheumatol. 2018;38(3):895-902. doi:10.1007/s10067-018-4385-7.
4. Bangsgaard N, Rørbye C, Skov L. Trea¬ting Psoriasis During Pregnancy: Sa¬fety and Efficacy of Treatments. Am J Clin Dermatol. 2015;16(5):389-98. doi:10.1007/s40257-015-0137-5.
5. Greb J, Goldminz A, Elder J, Lebwohl M, Gladman D, Wu J, Mehta nn, Finlay AY, Gottlieb AB. Pso¬riasis. Nat Rev Dis Primers. 2016;2:16082. doi.org/10.1038/nrdp.2016.82.
6. Yang C, Teeple M, Muglia J, Robinson-Bostom L. Inflammatory and glandular skin disease in pregnancy. Clin Dermatol. 2016;34(3):335-43. doi:10.1016/j.clindermatol.2016.02.005.
7. Helmick C, Lee-Han H, Hirsch S, Baird T, Bart¬lett C. Prevalence of Psoriasis Among Adults in the U.S. Am J Prevent Med. 2014;47(1):37-45. doi:10.1016/j.amepre.2014.02.012.
8. Henseler T, Christophers E. Psoriasis of early and late onset: Characterization of two types of psoriasis vulgaris. J Am Acad Dermatol. 1985;13(3):450-6. doi: 10.1016/s0190-9622(85)70188-0.
9. Kurizky P, Ferreira C, Nogueira L, Mota L. Treatment of psoriasis and psoriatic ar¬thritis during pregnancy and breastfeeding. An Bras Dermatol. 2015;90(3):367-75. doi:10.1590/abd1806-4841.20153113.
10. Johansen C, Jimenez-Solem E, Haerskjold A, Sand F, Thomsen S. The use and safety of TNF Inhibitors during pregnancy in women with pso¬riasis: A review. Int J Mol Sci. 2018;19(5):1349. doi:10.3390/ijms19051349.
11. Bobotsis R, Gulliver W, Monaghan K, Lynde C, Fleming P. Psoriasis and adverse pregnancy outcomes: a systematic review of observational studies. Br J Dermatol. 2016;175(3):464-72. doi: 10.1111/bjd.14547.
12. Rademaker M, Agnew K, Andrews M, Armour K, Baker C, Foley P, Frew J, Gebauer K, Gupta M, Kennedy D, Marshman G, Sullivan J. Psoriasis in those planning a family, pregnant or breast-feeding. The Australasian Psoriasis Collabora¬tion. Australas J Dermatol. 2017;59(2):86-100. doi:10.1111/ajd.12641.
13. Boyd A, Morris L, Phillips C, Menter M. Psoriasis and pregnancy: hormone and immune system in¬teraction. Int J Dermatol. 1996;35(3):169-72. doi: 10.1111/j.1365-4362.1996.tb01632.x.
14. Murase J, Chan K, Garite T, Cooper D, Weinstein G. Hormonal Effect on Psoriasis in Pregnancy and Post Partum. Arch Dermatol. 2005;141(5). doi: 10.1001/archderm.141.5.601.
15. Tauscher A, Fleischer A, Phelps K, Feldman S. Psoriasis and Pregnancy. J Cut Med Surg. 2002;6(6):561-70. doi: 10.1007/s10227-001-0147-1.
16. Hoffman M, Farhangian M, Feldman S. Pso¬riasis during pregnancy: characteristics and important management recommendations. Ex¬pert Rev Clin Immunol. 2015;11(6):709-20. doi:10.1586/1744666X.2015.1037742.
17. Franco M, González C, Londoño Á, Velázquez C, Cárdenas P, Colmenares L. Administración prác¬tica de la terapia convencional en psoriasis en la era de la terapia biológica. Dermatol Rev Mex. 2019;63(1):68-73.
18. Boehncke W. Etiology and Pathogenesis of Psoriasis. Rheum Dis Clin North Am. 2015;41(4):665-75. doi:10.1016/j.rdc.2015.07.013.
19. Valdimarsson H. The genetic basis of pso¬riasis. Clin Dermatol. 2007;25(6):563-7. doi: 10.1016/j.clindermatol.2007.08.010.
20. Boehncke W, Schön M. Psoriasis. Lancet. 2015;386(9997):983-94. doi: 10.1016/S0140-6736(14)61909-7.
21. Kang S, Amagai M, Bruckner A, Enk A, Margolis D, McMichael A, Orringer JS. Fitzpatrick’s Derma¬tology. 9.a edición. Estados Unidos: McGraw-Hill Education; 2019.
22. Fortes C, Mastroeni S, Leffondré K, Sampogna F, Melchi F, Mazzotti E, Pasquini P, Abeni D. Relation¬ship Between Smoking and the Clinical Severity of Psoriasis. Arch Dermatol. 2005;141(12):1580-4. doi: 10.1001/archderm.141.12.1580.
23. Higgins E. Psoriasis. Medi¬cine. 2017;45(6):368-78. doi: 10.1016/j.mpmed.2017.03.010.
24. Trivedi M, Vaughn A, Murase J. Pustular pso¬riasis of pregnancy: current perspectives. Int J Womens Health. 2018;10:109-15. doi: 10.2147/IJWH.S125784.
25. Capon F. The Genetic Basis of Pso¬riasis. Int J Mol Sci. 2017;18(12):2526. doi: 10.3390/ijms18122526.
26. Capon F, Munro M, Trembath R, Barker J. Searching for the Major Histocompatibi¬lity Complex Psoriasis Susceptibility Gene. J Invest Dermatol. 2002;118(5):745-51. doi: 10.1046/j.1523-1747.2002.01749.x.
27. Porter M, Lockwood S, Kimball A. Update on bio¬logic safety for patients with psoriasis during preg¬nancy. Int J Womens Dermatol. 2017;3(1):21-5. doi: 10.1016/j.ijwd.2016.12.003.
28. Kim W, Jerome D, Yeung J. Diagnosis and ma¬nagement of psoriasis. Can Fam Physician. 2017;63(1):278-285.
29. Allen H, Neidig L, Zhang J, Shaver C, Cusack C. The etiology of psoriasis: Its close association to strepto¬coccus. J Am Acad Dermatol. 2015;72(5):AB254. doi:10.1016/j.jaad.2015.02.1014.
30. Koca T. A short summary of clinical types of pso¬riasis. North Clin Istanb. 2016;3(1):79-82. doi:10.14744/nci.2016.16023.
31. Adil M, Arif T, Amin S. A comprehensive review on the pregnancy dermatoses. BJMP. 2016;9(1):a906.
32. Navarini A, Burden A, Capon F, Mrowietz U, Puig L, Köks S, Kingo K, Smith C, Barker JN; ERASPEN Network. European consensus state¬ment on phenotypes of pustular psoriasis. J Eur Acad Dermatol Venereol. 2017;31(11):1792-9. doi: 10.1111/jdv.14386.
33. Rahman M, Abdullah M, Hossain M, Siddique M, Nessa M, Rahman M, Sul¬tana S, Hossain M. Study of Nail Changes in Psoriasis. KYAMC J. 2017;8(1):24-6. doi: https://doi.org/10.3329/kyamcj.v8i2.35699.
34. Benjegerdes K, Hyde K, Kivelevitch D, Mansouri B. Pustular psoriasis: patho¬physiology and current treatment pers¬pectives. Psoriasis. 2016;6:131-44. doi:10.2147/PTT.S98954.
35. Hoegler K, John A, Handler M, Schwartz R. Generalized pustular psoriasis: a review and update on treatment. J Eur Acad Der-matol Venereol. 2018;32(10):1645-51. doi: 10.1111/jdv.14949.
36. Jin H, Cho H, Kim W, Mun J, Song M, Kim H, Ko HC, Kim MB, Kim H, Kim BS. Clinical fea¬tures and course of generalized pustular pso¬riasis in Korea. J Dermatol. 2015;42(7):674-8. doi:10.1111/1346-8138.12863.
37. Danesh M, Pomeranz M, McMeniman E, Murase J. Dermatoses of pregnancy: No¬menclature, misnomers, and myths. Clin Dermatol. 2016;34(3):314-9. doi: 10.1016/j.clindermatol.2016.02.002.
38. Razvi F, Haneef N, Teja V, Bang R, Hasnath F. Ge¬neralized pustular psoriasis of pregnancy. J Med Allied Sci. 2015;5(2):51-3.
39. Dogra S, Mahajan R. Psoriasis: Epidemiology, clinical features, co-morbidities, and clinical sco¬ring. Indian Dermatol Online J. 2016;7(6):471. doi: 10.4103/2229-5178.193906.
40. Griffiths C, Barker J, Bleiker T, Chalmers R, Creamer D. Rook’s textbook of dermatology. 9.a edición. Chichester, West Sussex: John Wiley & Sons Inc.; 2016.
41. Lund T, Thomsen S. Use of TNF-inhibitors and us¬tekinumab for psoriasis during pregnancy: A pa¬tient series. Dermatol Ther. 2017;30(3):e12454. doi: 10.1111/dth.12454.
42. Tyler K. Dermatologic Therapy in Pregnancy. Clin Obstet Gynecol. 2015;58(1):112-8. doi: 10.1097/GRF.0000000000000089.
43. Sandoval J, Sandoval C. Uso de fármacos durante el embarazo. Horiz Med. 2018;18(2):71-9.
44. Sociedad Argentina de Dermatología. Guía de tratamiento [Internet]. Disponible en: https://bit.ly/2LXgJmb.
45. Abrouk M, Nakamura M, Zhu T, Farahnik B, Koo J, Bhutani T. The impact of PASI 75 and PASI 90 on quality of life in moderate to severe psoriasis pa¬tients. J Dermatolog Treat. 2017;28(6):488-91. doi: 10.1080/09546634.2016.1278198.
46. Strober B, Papp K, Lebwohl M, Reich K, Paul C, Blauvelt A, Gordon KB, Milmont CE, Viswanathan HN, Li J, Pinto L, Harrison DJ, et al. Clinical meanin¬gfulness of complete skin clearance in psoriasis. J Am Acad Dermatol. 2016;75(1):77-82.e7. doi: 10.1016/j.jaad.2016.03.026.
47. Mason K, Williams S, Yiu Z, McElhone K, As¬hcroft D, Kleyn C, Jabbar-Lopez ZK, Owen CM, Reynolds NJ, Smith CH, Wilson N, Warren RB, et al. Persistence and effectiveness of non¬biologic systemic therapies for moderate-to-severe psoriasis in adults: a systematic re¬view. Br J Dermatol. 2019;181(2):256-64. doi: 10.1111/bjd.17625.
48. Walsh J, Tan H, Valdez H, Duffin K. Compa¬rative Assessment of PASI and Variations of PGA×BSA as Measures of Psoriasis Severity. J Psoriasis Psoriatic Arthritis. 2017;2(4):113-8. doi: https://doi.org/10.1177/247553031700200409.
49. Flor A, Martínez L, Méndez F, Hernández D, Mejía M, Barreira D. Actualización en el tratamiento de la psoriasis. Boletín Farmacoterapéutico de Castilla-La Mancha [Internet]. 2013;(14):1-8. Disponible en: https://bit.ly/2ZymLl7.
50. Acosta L, Gaviria C, Giraldo A, Mariaca J, Jiménez S. Fototerapia en combinación con otras tera¬pias en psoriasis. Rev Asoc Colomb Dermatol. 2016;24(4):264-76.
51. Echeverría-García B, Nuño-González A, Dauden E, Vanaclocha F, Torrado R, Belinchón I, Pérez-Zafrilla B; Grupo de estudio BIOBADADERM. Serie de casos de pacientes psoriásicas expuestas a terapia biológica durante el embarazo. Re¬gistro BIOBADADERM y revisión de la literatura. Actas Dermosifiliogr. 2017;108(2):168-70. doi: 10.1016/j.ad.2016.09.004.
52. Carrascosa J, Del-Alcazar E. New therapies versus first-generation biologic drugs in psoriasis: a re¬view of adverse events and their management. Expert Rev Clin Immunol. 2018;14(4):259-73. doi: 10.1080/1744666X.2018.1454835.
53. Alsenaid A, Prinz J. Inadvertent pregnancy during ustekinumab therapy in a patient with plaque psoriasis and impetigo herpetiformis. J Eur Acad Dermatol Venereol. 2014;30(3):488-90. doi: 10.1111/jdv.12872.
54. Vademecum. Apremilast [Internet]. Disponible en: https://bit.ly/36v1OJ4.
55. Galluzzo M, D’Adamio S, Bianchi L, Talamonti M. Psoriasis in pregnancy: case series and literature review of data concerning ex¬posure during pregnancy to ustekinumab. J Dermatolog Treat. 2018;30(1):40-4. doi: 10.1080/09546634.2018.1468066.
56. Mariette X, Förger F, Abraham B, Flynn A, Moltó A, Flipo R, van Tubergen A, Shaugh¬nessy L, Simpson J, Teil M, Helmer E, Wang M, et al. Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study. Ann Rheum Dis. 2018;77(2):228-33. doi: 10.1136/annrheumdis-2017-212196.
57. Clowse M, Förger F, Hwang C, Thorp J, Dolhain R, van Tubergen A, Shaughnessy L, Simpson J, Teil M, Toublanc N, Wang M, Hale TW. Mi¬nimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study. Ann Rheum Dis. 2017;76(11):1890-6. doi: 10.1136/annrheumdis-2017-211384.
58. Puchner A, Gröchenig H, Sautner J, Helmy-Bader Y, Juch H, Reinisch S, Högenauer C, Koch R, Hermann J, Studnicka-Benke A, Weger W, Puchner R, et al. Immunosuppressives and biologics during preg¬nancy and lactation: A Consensus Report Issued by the Austrian Societies of Gastroenterology and He¬patology and Rheumatology and Rehabilitation. Wien Klin Wochenschr. 2019;131(1-2):29-44. doi: 10.1007/s00508-019-1448-y.
59. Pottinger E, Woolf R, Exton L, Burden A, Nelson-Piercy C, Smith C. Exposure to biological therapies during conception and pregnancy: a systematic review. Br J Dermatol. 2017;178(1):95-102. doi: 10.1111/bjd.15802.
2. Polachek A, Li S, Polachek I, Chandran V, Gladman D. Psoriatic arthritis disease activity during pregnancy and the first-year postpartum. Semin Arthritis Rheum. 2017;46(6):740-5. doi:10.1016/j.semarthrit.2017.01.002.
3. Polachek A, Polachek Shlomi I, Spitzer K, Pe¬reira D, Ye J, Chandran V, Laskin CA, Gladman DD. Outcome of pregnancy in women with psoriatic arthritis compared to healthy con¬trols. Clin Rheumatol. 2018;38(3):895-902. doi:10.1007/s10067-018-4385-7.
4. Bangsgaard N, Rørbye C, Skov L. Trea¬ting Psoriasis During Pregnancy: Sa¬fety and Efficacy of Treatments. Am J Clin Dermatol. 2015;16(5):389-98. doi:10.1007/s40257-015-0137-5.
5. Greb J, Goldminz A, Elder J, Lebwohl M, Gladman D, Wu J, Mehta nn, Finlay AY, Gottlieb AB. Pso¬riasis. Nat Rev Dis Primers. 2016;2:16082. doi.org/10.1038/nrdp.2016.82.
6. Yang C, Teeple M, Muglia J, Robinson-Bostom L. Inflammatory and glandular skin disease in pregnancy. Clin Dermatol. 2016;34(3):335-43. doi:10.1016/j.clindermatol.2016.02.005.
7. Helmick C, Lee-Han H, Hirsch S, Baird T, Bart¬lett C. Prevalence of Psoriasis Among Adults in the U.S. Am J Prevent Med. 2014;47(1):37-45. doi:10.1016/j.amepre.2014.02.012.
8. Henseler T, Christophers E. Psoriasis of early and late onset: Characterization of two types of psoriasis vulgaris. J Am Acad Dermatol. 1985;13(3):450-6. doi: 10.1016/s0190-9622(85)70188-0.
9. Kurizky P, Ferreira C, Nogueira L, Mota L. Treatment of psoriasis and psoriatic ar¬thritis during pregnancy and breastfeeding. An Bras Dermatol. 2015;90(3):367-75. doi:10.1590/abd1806-4841.20153113.
10. Johansen C, Jimenez-Solem E, Haerskjold A, Sand F, Thomsen S. The use and safety of TNF Inhibitors during pregnancy in women with pso¬riasis: A review. Int J Mol Sci. 2018;19(5):1349. doi:10.3390/ijms19051349.
11. Bobotsis R, Gulliver W, Monaghan K, Lynde C, Fleming P. Psoriasis and adverse pregnancy outcomes: a systematic review of observational studies. Br J Dermatol. 2016;175(3):464-72. doi: 10.1111/bjd.14547.
12. Rademaker M, Agnew K, Andrews M, Armour K, Baker C, Foley P, Frew J, Gebauer K, Gupta M, Kennedy D, Marshman G, Sullivan J. Psoriasis in those planning a family, pregnant or breast-feeding. The Australasian Psoriasis Collabora¬tion. Australas J Dermatol. 2017;59(2):86-100. doi:10.1111/ajd.12641.
13. Boyd A, Morris L, Phillips C, Menter M. Psoriasis and pregnancy: hormone and immune system in¬teraction. Int J Dermatol. 1996;35(3):169-72. doi: 10.1111/j.1365-4362.1996.tb01632.x.
14. Murase J, Chan K, Garite T, Cooper D, Weinstein G. Hormonal Effect on Psoriasis in Pregnancy and Post Partum. Arch Dermatol. 2005;141(5). doi: 10.1001/archderm.141.5.601.
15. Tauscher A, Fleischer A, Phelps K, Feldman S. Psoriasis and Pregnancy. J Cut Med Surg. 2002;6(6):561-70. doi: 10.1007/s10227-001-0147-1.
16. Hoffman M, Farhangian M, Feldman S. Pso¬riasis during pregnancy: characteristics and important management recommendations. Ex¬pert Rev Clin Immunol. 2015;11(6):709-20. doi:10.1586/1744666X.2015.1037742.
17. Franco M, González C, Londoño Á, Velázquez C, Cárdenas P, Colmenares L. Administración prác¬tica de la terapia convencional en psoriasis en la era de la terapia biológica. Dermatol Rev Mex. 2019;63(1):68-73.
18. Boehncke W. Etiology and Pathogenesis of Psoriasis. Rheum Dis Clin North Am. 2015;41(4):665-75. doi:10.1016/j.rdc.2015.07.013.
19. Valdimarsson H. The genetic basis of pso¬riasis. Clin Dermatol. 2007;25(6):563-7. doi: 10.1016/j.clindermatol.2007.08.010.
20. Boehncke W, Schön M. Psoriasis. Lancet. 2015;386(9997):983-94. doi: 10.1016/S0140-6736(14)61909-7.
21. Kang S, Amagai M, Bruckner A, Enk A, Margolis D, McMichael A, Orringer JS. Fitzpatrick’s Derma¬tology. 9.a edición. Estados Unidos: McGraw-Hill Education; 2019.
22. Fortes C, Mastroeni S, Leffondré K, Sampogna F, Melchi F, Mazzotti E, Pasquini P, Abeni D. Relation¬ship Between Smoking and the Clinical Severity of Psoriasis. Arch Dermatol. 2005;141(12):1580-4. doi: 10.1001/archderm.141.12.1580.
23. Higgins E. Psoriasis. Medi¬cine. 2017;45(6):368-78. doi: 10.1016/j.mpmed.2017.03.010.
24. Trivedi M, Vaughn A, Murase J. Pustular pso¬riasis of pregnancy: current perspectives. Int J Womens Health. 2018;10:109-15. doi: 10.2147/IJWH.S125784.
25. Capon F. The Genetic Basis of Pso¬riasis. Int J Mol Sci. 2017;18(12):2526. doi: 10.3390/ijms18122526.
26. Capon F, Munro M, Trembath R, Barker J. Searching for the Major Histocompatibi¬lity Complex Psoriasis Susceptibility Gene. J Invest Dermatol. 2002;118(5):745-51. doi: 10.1046/j.1523-1747.2002.01749.x.
27. Porter M, Lockwood S, Kimball A. Update on bio¬logic safety for patients with psoriasis during preg¬nancy. Int J Womens Dermatol. 2017;3(1):21-5. doi: 10.1016/j.ijwd.2016.12.003.
28. Kim W, Jerome D, Yeung J. Diagnosis and ma¬nagement of psoriasis. Can Fam Physician. 2017;63(1):278-285.
29. Allen H, Neidig L, Zhang J, Shaver C, Cusack C. The etiology of psoriasis: Its close association to strepto¬coccus. J Am Acad Dermatol. 2015;72(5):AB254. doi:10.1016/j.jaad.2015.02.1014.
30. Koca T. A short summary of clinical types of pso¬riasis. North Clin Istanb. 2016;3(1):79-82. doi:10.14744/nci.2016.16023.
31. Adil M, Arif T, Amin S. A comprehensive review on the pregnancy dermatoses. BJMP. 2016;9(1):a906.
32. Navarini A, Burden A, Capon F, Mrowietz U, Puig L, Köks S, Kingo K, Smith C, Barker JN; ERASPEN Network. European consensus state¬ment on phenotypes of pustular psoriasis. J Eur Acad Dermatol Venereol. 2017;31(11):1792-9. doi: 10.1111/jdv.14386.
33. Rahman M, Abdullah M, Hossain M, Siddique M, Nessa M, Rahman M, Sul¬tana S, Hossain M. Study of Nail Changes in Psoriasis. KYAMC J. 2017;8(1):24-6. doi: https://doi.org/10.3329/kyamcj.v8i2.35699.
34. Benjegerdes K, Hyde K, Kivelevitch D, Mansouri B. Pustular psoriasis: patho¬physiology and current treatment pers¬pectives. Psoriasis. 2016;6:131-44. doi:10.2147/PTT.S98954.
35. Hoegler K, John A, Handler M, Schwartz R. Generalized pustular psoriasis: a review and update on treatment. J Eur Acad Der-matol Venereol. 2018;32(10):1645-51. doi: 10.1111/jdv.14949.
36. Jin H, Cho H, Kim W, Mun J, Song M, Kim H, Ko HC, Kim MB, Kim H, Kim BS. Clinical fea¬tures and course of generalized pustular pso¬riasis in Korea. J Dermatol. 2015;42(7):674-8. doi:10.1111/1346-8138.12863.
37. Danesh M, Pomeranz M, McMeniman E, Murase J. Dermatoses of pregnancy: No¬menclature, misnomers, and myths. Clin Dermatol. 2016;34(3):314-9. doi: 10.1016/j.clindermatol.2016.02.002.
38. Razvi F, Haneef N, Teja V, Bang R, Hasnath F. Ge¬neralized pustular psoriasis of pregnancy. J Med Allied Sci. 2015;5(2):51-3.
39. Dogra S, Mahajan R. Psoriasis: Epidemiology, clinical features, co-morbidities, and clinical sco¬ring. Indian Dermatol Online J. 2016;7(6):471. doi: 10.4103/2229-5178.193906.
40. Griffiths C, Barker J, Bleiker T, Chalmers R, Creamer D. Rook’s textbook of dermatology. 9.a edición. Chichester, West Sussex: John Wiley & Sons Inc.; 2016.
41. Lund T, Thomsen S. Use of TNF-inhibitors and us¬tekinumab for psoriasis during pregnancy: A pa¬tient series. Dermatol Ther. 2017;30(3):e12454. doi: 10.1111/dth.12454.
42. Tyler K. Dermatologic Therapy in Pregnancy. Clin Obstet Gynecol. 2015;58(1):112-8. doi: 10.1097/GRF.0000000000000089.
43. Sandoval J, Sandoval C. Uso de fármacos durante el embarazo. Horiz Med. 2018;18(2):71-9.
44. Sociedad Argentina de Dermatología. Guía de tratamiento [Internet]. Disponible en: https://bit.ly/2LXgJmb.
45. Abrouk M, Nakamura M, Zhu T, Farahnik B, Koo J, Bhutani T. The impact of PASI 75 and PASI 90 on quality of life in moderate to severe psoriasis pa¬tients. J Dermatolog Treat. 2017;28(6):488-91. doi: 10.1080/09546634.2016.1278198.
46. Strober B, Papp K, Lebwohl M, Reich K, Paul C, Blauvelt A, Gordon KB, Milmont CE, Viswanathan HN, Li J, Pinto L, Harrison DJ, et al. Clinical meanin¬gfulness of complete skin clearance in psoriasis. J Am Acad Dermatol. 2016;75(1):77-82.e7. doi: 10.1016/j.jaad.2016.03.026.
47. Mason K, Williams S, Yiu Z, McElhone K, As¬hcroft D, Kleyn C, Jabbar-Lopez ZK, Owen CM, Reynolds NJ, Smith CH, Wilson N, Warren RB, et al. Persistence and effectiveness of non¬biologic systemic therapies for moderate-to-severe psoriasis in adults: a systematic re¬view. Br J Dermatol. 2019;181(2):256-64. doi: 10.1111/bjd.17625.
48. Walsh J, Tan H, Valdez H, Duffin K. Compa¬rative Assessment of PASI and Variations of PGA×BSA as Measures of Psoriasis Severity. J Psoriasis Psoriatic Arthritis. 2017;2(4):113-8. doi: https://doi.org/10.1177/247553031700200409.
49. Flor A, Martínez L, Méndez F, Hernández D, Mejía M, Barreira D. Actualización en el tratamiento de la psoriasis. Boletín Farmacoterapéutico de Castilla-La Mancha [Internet]. 2013;(14):1-8. Disponible en: https://bit.ly/2ZymLl7.
50. Acosta L, Gaviria C, Giraldo A, Mariaca J, Jiménez S. Fototerapia en combinación con otras tera¬pias en psoriasis. Rev Asoc Colomb Dermatol. 2016;24(4):264-76.
51. Echeverría-García B, Nuño-González A, Dauden E, Vanaclocha F, Torrado R, Belinchón I, Pérez-Zafrilla B; Grupo de estudio BIOBADADERM. Serie de casos de pacientes psoriásicas expuestas a terapia biológica durante el embarazo. Re¬gistro BIOBADADERM y revisión de la literatura. Actas Dermosifiliogr. 2017;108(2):168-70. doi: 10.1016/j.ad.2016.09.004.
52. Carrascosa J, Del-Alcazar E. New therapies versus first-generation biologic drugs in psoriasis: a re¬view of adverse events and their management. Expert Rev Clin Immunol. 2018;14(4):259-73. doi: 10.1080/1744666X.2018.1454835.
53. Alsenaid A, Prinz J. Inadvertent pregnancy during ustekinumab therapy in a patient with plaque psoriasis and impetigo herpetiformis. J Eur Acad Dermatol Venereol. 2014;30(3):488-90. doi: 10.1111/jdv.12872.
54. Vademecum. Apremilast [Internet]. Disponible en: https://bit.ly/36v1OJ4.
55. Galluzzo M, D’Adamio S, Bianchi L, Talamonti M. Psoriasis in pregnancy: case series and literature review of data concerning ex¬posure during pregnancy to ustekinumab. J Dermatolog Treat. 2018;30(1):40-4. doi: 10.1080/09546634.2018.1468066.
56. Mariette X, Förger F, Abraham B, Flynn A, Moltó A, Flipo R, van Tubergen A, Shaugh¬nessy L, Simpson J, Teil M, Helmer E, Wang M, et al. Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study. Ann Rheum Dis. 2018;77(2):228-33. doi: 10.1136/annrheumdis-2017-212196.
57. Clowse M, Förger F, Hwang C, Thorp J, Dolhain R, van Tubergen A, Shaughnessy L, Simpson J, Teil M, Toublanc N, Wang M, Hale TW. Mi¬nimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study. Ann Rheum Dis. 2017;76(11):1890-6. doi: 10.1136/annrheumdis-2017-211384.
58. Puchner A, Gröchenig H, Sautner J, Helmy-Bader Y, Juch H, Reinisch S, Högenauer C, Koch R, Hermann J, Studnicka-Benke A, Weger W, Puchner R, et al. Immunosuppressives and biologics during preg¬nancy and lactation: A Consensus Report Issued by the Austrian Societies of Gastroenterology and He¬patology and Rheumatology and Rehabilitation. Wien Klin Wochenschr. 2019;131(1-2):29-44. doi: 10.1007/s00508-019-1448-y.
59. Pottinger E, Woolf R, Exton L, Burden A, Nelson-Piercy C, Smith C. Exposure to biological therapies during conception and pregnancy: a systematic review. Br J Dermatol. 2017;178(1):95-102. doi: 10.1111/bjd.15802.
How to Cite
1.
Barquero-Orias D, Martínez-Franco MC. Principles of psoriasis and therapeutic approach in pregnancy: literature review. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 2020 Oct. 19 [cited 2024 Jul. 3];28(2):148-63. Available from: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/1519
Downloads
Download data is not yet available.
Downloads
Published
2020-10-19
How to Cite
1.
Barquero-Orias D, Martínez-Franco MC. Principles of psoriasis and therapeutic approach in pregnancy: literature review. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 2020 Oct. 19 [cited 2024 Jul. 3];28(2):148-63. Available from: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/1519
Issue
Section
Review Article
License
Copyright (c) 2020 Revista de la Asociación Colombiana de Dermatología y Cirugía Dermatológica
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
